Daily Stock Setups

Reportbuyer: New Report Offers Detailed Guidance to Watson Pharmaceuticals

Posted on: Sat, 07 Feb 2009 07:08:00 EST

Symbols: WPI

Are you looking to increase your ETF knowledge?

Feb 06, 2009 (M2 PRESSWIRE via COMTEX) --
WPI | Quote | Chart | News | PowerRating -- Report Buyer, the online destination for business intelligence for major industry sectors, has added now added a report providing a vital information on Watson Pharmaceuticals.

The report "Watson Pharmaceuticals Inc.: PharmaVitae Profile", available at http://www.reportbuyer.com/go/DAT14061 examines the performance of the leading specialty pharmaceutical company Watson in the prescription pharmaceutical sector.

The profile encompasses global company strategy, portfolio and pipeline analysis with 1-6 year sales forecasts for key drugs. In addition to this, an interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

Consisting of eight chapters, the 118-page report contains an introduction to the company and a comprehensive guide to its latest developments, company sales and financial, and an in-depth overview of the company's key products and competitors.

The report is of crucial importance to anyone operating in this market segment as it

* Benchmarks Watson's performance against key rivals in the prescription pharmaceutical sector.

* Assesses how large scale M&A activity undertaken by a number of Watson's peers has intensified competitive threat to future sales growth.

* Analyses how Watson will seek to bolster its performance in the generic pharmaceutical market via its branded offering and distribution business.

"Watson Pharmaceuticals Inc.: PharmaVitae Profile" is available from Report Buyer. For more information, go to: http://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/watson_pharmaceuticals_inc_pharmavitae_profile.html

Report Buyer product ID: DAT14061

About Report Buyer.

Report Buyer (http://www.reportbuyer.com/pharma_healthcare) is a UK-based independent online store supplying business information. The website now carries over 90,000 business information products, including market reports, studies, books and events.

CONTACT: Report Buyer
Tel: +44 (0)20 7060 7474
WWW: http://www.reportbuyer.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details on Watson Pharmaceuticals (WPI) WPI. Watson Pharmaceuticals (WPI) has Short Term PowerRatings at TradingMarkets. Details on Watson Pharmaceuticals (WPI) Short Term PowerRatings is available at This Link.

More News: Market Updates | Stock Alerts | All Trading News

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.